Key result
Reperfusion therapy cuts mortality and salvages viable myocardium in acute myocardial infarction.
Why the study?
It is uncertain whether left ventricular ejection fraction and infarct size are adequate surrogate measures for the effects of reperfusion therapy on mortality and morbidity in acute myocardial infarction patients.
Are left ventricular ejection fraction and infarct size adequate 'surrogate' measures for the effects on mortality and morbidity in acute myocardial infarction patients?
Are left ventricular ejection fraction and infarct size adequate 'surrogate' measures for the effects on mortality and morbidity in acute myocardial infarction patients?
This paper discusses the adequacy of left ventricular ejection fraction and infarct size as surrogate measures for mortality and morbidity in acute myocardial infarction.
Reperfusion therapy preserves viable myocardial tissue and reduces mortality in acute myocardial infarction patients. Are left ventricular ejection fraction and infarct size adequate 'surrogate' measures for the effects on mortality and morbidity?Infarct size can be measured from the total quantity of enzymes or other proteins released from the 0195-668X/97/091371 + 14 S18.
No takes yet. Share an insight, caveat, or question.
Werf et al. (1997) studied this question. Reperfusion therapy preserves viable myocardial tissue and reduces mortality in patients with acute myocardial infarction.
Synapse has enriched 5 related papers. Consider them for comparative context: